| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0003 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0003 |
| mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0003 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0005 |
| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0005 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0006 |
| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0006 |
| mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0007 |
| mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0007 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0008 |